Cargando…

Residual insomnia in major depressive disorder: a systematic review

INTRODUCTION: The ultimate goal in major depressive disorder (MDD) treatment is recovery. A proportion of MDD patients with formal remission experience persistent difficulties, which impair their daily functioning. Residual insomnia is one of the most common residual symptoms. Patients with residual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwaśny, Aleksander, Włodarczyk, Adam, Dywel, Alicja, Szarmach, Joanna, Strandberg, Olivia, Cubała, Wiesław Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312086/ https://www.ncbi.nlm.nih.gov/pubmed/37398584 http://dx.doi.org/10.3389/fpsyt.2023.1190415

Ejemplares similares

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
por: Włodarczyk, Adam, et al.
Publicado: (2023)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2020)

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study
por: Szarmach, Joanna, et al.
Publicado: (2017)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Dysphoria and Irritability—Diagnostic Pitfalls in the Assessment of Interictal Dysphoric Disorder in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis
por: Włodarczyk, Adam, et al.
Publicado: (2020)

Increased Salience Network Activity in Patients With Insomnia Complaints in Major Depressive Disorder
por: Liu, Chun-Hong, et al.
Publicado: (2018)

Transdiagnostic association between subjective insomnia and depressive symptoms in major psychiatric disorders
por: Nakajima, Suguru, et al.
Publicado: (2023)

The aberrant dynamic amplitude of low-frequency fluctuations in melancholic major depressive disorder with insomnia
por: Deng, Zijing, et al.
Publicado: (2022)

Suprachiasmatic nucleus functional connectivity related to insomnia symptoms in adolescents with major depressive disorder
por: Cao, Lingling, et al.
Publicado: (2023)

The Role of Acupuncture in the Management of Insomnia as a Major or Residual Symptom Among Patients With Active or Previous Depression: A Systematic Review and Meta-Analysis
por: Zhao, Fei-Yi, et al.
Publicado: (2022)

Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports
por: Wilkowska, Alina, et al.
Publicado: (2019)

Potential Genetic Overlap Between Insomnia and Sleep Symptoms in Major Depressive Disorder: A Polygenic Risk Score Analysis
por: Melhuish Beaupre, Lindsay M., et al.
Publicado: (2021)

Dietary Patterns of Treatment–Resistant Depression Patients
por: Mechlińska, Agnieszka, et al.
Publicado: (2022)

Corrigendum: Potential genetic overlap between insomnia and sleep symptoms in major depressive disorder: A polygenic risk score analysis
por: Melhuish Beaupre, Lindsay M., et al.
Publicado: (2022)

Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
por: Wichniak, Adam, et al.
Publicado: (2021)

Ketogenic Diet: A Dietary Modification as an Anxiolytic Approach?
por: Włodarczyk, Adam, et al.
Publicado: (2020)

The Contribution of Posttraumatic Stress Disorder and Depression to Insomnia in North Korean Refugee Youth
por: Park, Jinme, et al.
Publicado: (2019)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
por: Myklebost, Sunniva Brurok, et al.
Publicado: (2022)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia
por: An, Ji Hyun, et al.
Publicado: (2020)

Corrigendum: The Contribution of Posttraumatic Stress Disorder and Depression to Insomnia in North Korean Refugee Youth
por: Park, Jinme, et al.
Publicado: (2020)

The Role of Microbiome in Insomnia, Circadian Disturbance and Depression
por: Li, Yuanyuan, et al.
Publicado: (2018)

Orbitofrontal Cortex Functional Connectivity-Based Classification for Chronic Insomnia Disorder Patients With Depression Symptoms
por: Gong, Liang, et al.
Publicado: (2022)

Insomnia in the Italian Population During Covid-19 Outbreak: A Snapshot on One Major Risk Factor for Depression and Anxiety
por: Bacaro, Valeria, et al.
Publicado: (2020)

Effect of insomnia in the major depressive disorder
por: Xu, Guohong, et al.
Publicado: (2022)

Depression, anxiety, insomnia and interleukins in the early postpartum period
por: Drozdowicz-Jastrzębska, Ewa, et al.
Publicado: (2023)

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Eye Movement Abnormalities in Major Depressive Disorder
por: Takahashi, Junichi, et al.
Publicado: (2021)

Cortical Inhibition and Plasticity in Major Depressive Disorder
por: Castricum, Jesminne, et al.
Publicado: (2022)

The roles of extracellular vesicles in major depressive disorder
por: Li, Ying, et al.
Publicado: (2023)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p9qkko9vfv06q4pk4lla0aj94n